Basilea Pharmaceutica Is A Swiss Biopharmaceutical Company Focused On Developing Anti Infective Therapiesfounded In 2000 As A Spin Off From Fhoffmann La Rocheit Became Publicly Listed In 2004 And Is Headquartered In Allschwilswitzerlandthe Company Employs Around 150 People And Aims To Combat Antimicrobial Resistance Through Innovative Drug Development Basilea S Product Portfolio Includes Cresembaa Isavuconazole An Antifungal For Invasive Aspergillosis And Mucormycosiszevteraa Ceftobiprole A Broad Spectrum Antibiotic For Bacterial Infectionsand Toctinoa Alitretinoin A Treatment For Severe Chronic Hand Eczemathe Company Collaborates With Partners Like Astellas Pharma And Pfizer To Commercialize Its Products In Over 100 Countriesbasilea Also Has A Robust Pipeline Of Preclinical And Clinical Stage Anti Infectives Targeting Resistant Pathogenssupported By Various Partnerships With Pharmaceutical Distributors And Healthcare Providers Globally
